Literature DB >> 11214926

Quantitative traits of prion strains are enciphered in the conformation of the prion protein.

J Safar1, F E Cohen, S B Prusiner.   

Abstract

Variations in prions, which cause different disease phenotypes, are often referred to as strains. Strains replicate with a high degree of fidelity, which demands a mechanism that can account for this phenomenon. Prion strains differ by qualitative characteristics such as clinical symptoms, brain pathology, topology of accumulated PrP(Sc), and Western blot patterns of glycosylated or deglycosylated PrP(Sc). Since none of these qualitative features can directly explain quantitative strain traits such as incubation time or dose response, we analyzed conformational parameters of PrP(Sc) and the rate of accumulation in different prion strains. Using the conformation-dependent immunoassay (CDI), we were able to discriminate among PrP(Sc) molecules from eight different prion strains propagated in Syrian hamsters. CDI quantifies PrP isoforms by simultaneously following antibody binding to both the denatured and native forms of a protein. In a plot of the ratio of antibody binding to denatured/native PrP graphed as a function of the concentration of PrP(Sc), each strain occupied a unique position, indicating that each strain accumulated different concentrations of particular PrP(Sc) conformers. This conclusion was supported by a unique pattern of equilibrium unfolding of PrP(Sc) found within each strain. By comparing the PrP(Sc) levels before and after limited proteinase K digestion, we found that each strain produces a substantial fraction of protease-sensitive PrP(Sc). We asked whether this fraction of PrP(Sc) might reflect those PrP(Sc) molecules that are most readily cleared by cellular proteases. When the protease-sensitive PrP(Sc) fraction was plotted as a function of the incubation time, a linear relationship was found with an excellent correlation coefficient (r = 0.94). Combined with the data on time courses of prion infection in Tg(MHu2M) and Tg(SHaPrP) mice, the results argue that different incubation times of various prion strains may arise predominantly from distinct rates of PrP(Sc) clearance rather than from different rates of PrP(Sc) formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11214926     DOI: 10.1007/978-3-7091-6308-5_22

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  11 in total

1.  Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD).

Authors:  Johannes Brettschneider; Kelly Del Tredici; David J Irwin; Murray Grossman; John L Robinson; Jon B Toledo; Lubin Fang; Vivianna M Van Deerlin; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-01-10       Impact factor: 17.088

Review 2.  Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.

Authors:  Brandon B Holmes; Marc I Diamond
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

3.  Modification of blood cell PrP epitope exposure during prion disease.

Authors:  Alana M Thackray; Stephen J Ryder; Raymond Bujdoso
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

4.  Cell-free formation of misfolded prion protein with authentic prion infectivity.

Authors:  Petra Weber; Armin Giese; Niklas Piening; Gerda Mitteregger; Achim Thomzig; Michael Beekes; Hans A Kretzschmar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

5.  Novel antibody-lectin enzyme-linked immunosorbent assay that distinguishes prion proteins in sporadic and variant cases of Creutzfeldt-Jakob disease.

Authors:  Tao Pan; Ruliang Li; Boon-Seng Wong; Shin-Chung Kang; James Ironside; Man-Sun Sy
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

Review 6.  Prion interference with multiple prion isolates.

Authors:  Charles R Schutt; Jason C Bartz
Journal:  Prion       Date:  2008-04-18       Impact factor: 3.931

7.  Cryptic peptides of the kringle domains preferentially bind to disease-associated prion protein.

Authors:  Kristen Hatcher; Jian Zheng; Shu G Chen
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 8.  Prion protein conversion in vitro.

Authors:  Surachai Supattapone
Journal:  J Mol Med (Berl)       Date:  2004-03-10       Impact factor: 4.599

9.  Direct detection of disease associated prions in brain and lymphoid tissue using antibodies recognizing the extreme N terminus of PrPC.

Authors:  Geoff Barnard; Lee Hopkins; Sowmiya Moorthie; David Seilly; Paul Tonks; Reza Dabaghian; Jonathan Clewley; John Coward; Ian McConnell
Journal:  Prion       Date:  2007-04-15       Impact factor: 3.931

10.  Spontaneous variants of the [RNQ+] prion in yeast demonstrate the extensive conformational diversity possible with prion proteins.

Authors:  Vincent J Huang; Kevin C Stein; Heather L True
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.